Načítá se...
Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer
Most differentiated thyroid cancer (DTC) patients have an excellent prognosis. However, about one-third of DTC patients with recurrent or metastatic disease lose the hallmark of specific iodine uptake initially or gradually and acquire radioactive iodine-refractory DTC (RAIR-DTC) with poor prognosis...
Uloženo v:
| Vydáno v: | Chonnam Med J |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Chonnam National University Medical School
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6769251/ https://ncbi.nlm.nih.gov/pubmed/31598469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4068/cmj.2019.55.3.127 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|